Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation (Q48742830)

15 February 2018

title

Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation (English)

1 reference

15 February 2018

1 reference

C Brewer

1

1 reference

15 February 2018

publication date

1 July 1997

1 reference

15 February 2018

published in

Addiction Biology

1 reference

15 February 2018

volume

2

1 reference

15 February 2018

issue

3

1 reference

15 February 2018

page(s)

291-302

1 reference

15 February 2018

Alcoholism treatment by disulfiram and community reinforcement therapy.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Letter: Suicide with tricyclic antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Naloxone and opiate addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Combining pharmacological antagonists and behavioural psychotherapy in treating addictions. Why it is effective but unpopular

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Anaesthesia or sedation for drug misusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Detoxification from methadone maintenance treatment in Sweden: long-term outcome and effects on quality of life and life situation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Rapid opiate detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Opioid antagonist challenges in buprenorphine maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Long-term sensitization to the behavioral effects of naltrexone is associated with regionally specific changes in the number of mu and delta opioid receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Comparison of ketamine and pethidine in experimental and postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Octreotide in relieving gastrointestinal symptoms due to bowel obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Prevalence and diagnostic reliability of methadone maintenance detoxification fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Primary care-based ambulatory opioid detoxification: the results of a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Behavioral assessment of narcotic detoxification fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Experience with clonidine-naltrexone for rapid opiate detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

The efficacy of naltrexone in preventing reabuse of heroin after detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Somatostatin in gastroenterology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Narcotic withdrawal syndrome caused by naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Clinical Utility of Rapid Clonidine-naltrcxone Detoxification for Opioid Abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219772589

21 January 2018

Identifiers

DOI

10.1080/13556219772589

1 reference

15 February 2018

1 reference

15 February 2018